USH2A gene therapy(SalioGen Therapeutics)

N/A

Report date: 2024/05/13 16:58:23

Base Information

Drug NameUSH2A gene therapy(SalioGen Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUsherin modulators
TargetsUsherin
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSaliogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSaliogen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A